Adolf et al., 1991 - Google Patents
Natural human interferon-α2 is O-glycosylatedAdolf et al., 1991
View PDF- Document ID
- 15282460408012610113
- Author
- Adolf G
- Kalsner I
- Ahorn H
- Maurer-Fogy I
- Cantell K
- Publication year
- Publication venue
- Biochemical Journal
External Links
Snippet
Natural human interferon alpha 2 (IFN-alpha 2) was isolated from a preparation of partially purified human leucocyte IFN by monoclonal-antibody immunoaffinity chromatography. The purified protein had a specific activity of 1.5 x 10 (8) iu/mg; it was estimated to constitute 10 …
- 108010078049 Interferon alpha-2 0 title abstract description 11
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adolf et al. | Natural human interferon-α2 is O-glycosylated | |
| KR100223255B1 (en) | Improved Alpha Interferon Compositions and Methods of Preparation from Human Peripheral Blood Leukocytes | |
| HIRABAYASHI et al. | Complete amino acid sequence of 14 kDa β-galactoside-binding lectin of chick embryo | |
| Allen et al. | A family of structural genes for human lymphoblastoid (leukocyte-type) interferon | |
| AU650893B2 (en) | O-glycosylated alpha-2 interferon | |
| NYMAN et al. | Identification of nine interferon-α subtypes produced by Sendai virus-induced human peripheral blood leucocytes | |
| Dorner et al. | Purification, structural analysis, and function of natural ATAC, a cytokine secreted by CD8+ T cells | |
| VOSS et al. | Expression of human interferon ω1 in Sf9 cells: No evidence for complex‐type N‐linked glycosylation or sialylation | |
| EP0905240A1 (en) | Amino-terminally truncated c-c chemokines as chemokine antagonists | |
| Yoshiyama et al. | Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor | |
| US4765903A (en) | Purification of monomeric interferon | |
| US20100261275A1 (en) | Production of Recombinant Interferon Proteins | |
| Sugyiama et al. | Expression of human interferon‐α2 in Sf9 cells: Characterization of O‐linked glycosylation and protein heterogeneities | |
| NZ203364A (en) | Method for purifying human immune interferon;homogeneous human immune interferon | |
| Adolf et al. | Human interferon ω1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein | |
| US4908432A (en) | Novel polypeptide having gamma-interferon activity | |
| HOSOI et al. | Structural characterization of fibroblast human interferon-β1 | |
| KR940010024B1 (en) | Process for the preparation and purification of alpha-interferon | |
| Kawade et al. | Characterization of rat monoclonal antibodies to mouse interferon-α and-β | |
| DIPAOLA et al. | Interferon-α2 produced by normal human leukocytes is predominantly interferon-α2b | |
| KR100382628B1 (en) | Interferonα / β-binding Protein and Its Preparation and Use | |
| CA1101842A (en) | THYMOSIN .alpha.1 | |
| Niu et al. | Atypical porcine type I interferon: biochemical and biological characterization of the recombinant protein expressed in insect cells | |
| US6774220B1 (en) | Compounds having lectinic properties and their biological applications | |
| Hayes | Differences between human α (leukocyte) and β (fibroblast) interferons |